| Inventor | Institute |
|---|---|
| Markku Varjosalo | University of Helsinki |
| SKU: | 162368 |
|---|---|
| Product description: | Flp-In™ T-REx™ 293 cells expressing ETV6-NTRK3 (EN) variant 1 (EN4) |
| Gender: | Male |
| CRISPR: | Yes |
| Conditional: | Yes |
| Parental cell line: | Flp-In™ T-REx™ 293 |
| Cat. #: | 162368 |
|---|---|
| Tool sub type: | 10XUAS IVS p10 |
| Cancer types: | Breast cancer |
| Organism: | Human |
| Tissue: | Kidney |
| Gender: | Male |
| Model: | Genetically modified cell line |
| Primary citation: | Kinnunen et al. (2023). Cancers (Basel). 15(17):4246. PMID: 37686522 |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | Low-glucose DMEM pH 7.4 supplemented with penicillin–streptomycin and 10% FBS |
| Atmosphere: | 5% CO2 |
| Mycoplasma free: | Yes |
| Biosafety level: | 2 |
| References: |
Kinnunen et al. (2023). Cancers (Basel). 15(17):4246. PMID: 37686522 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.